findmyKOL
Clinical trialNCT01578967CompletedInterventional

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

SponsorUNC Lineberger Comprehensive Cancer CenterEnrollment41Hodgkin Lymphoma, Adult
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope Comprehensive Cancer Center

    Duarte, California, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, United States

  • Levine Cancer Istitute, Carolinas Health Care System

    Charlotte, North Carolina, United States

  • Rex Cancer Center

    Raleigh, North Carolina, United States

  • Vanderbilt University

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2012
Primary completion
10 Aug 2016
Completion
11 Dec 2020
Last update posted
7 Dec 2021
Registered enrollment
41
Registry id
NCT01578967

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.